Share

Effects of extremely low frequency electromagnetic field (EMF) on collagen type I mRNA expression and extracellular matrix synthesis of human osteoblastic cells.

K Heermeier, M Spanner, J Träger, R Gradinger, P G Strauss, W Kraus, J Schmidt

PAPERpubmedBioelectromagnetics1998In vitro studyEffect: benefitEvidence: Low

Abstract

Human osteoblastic cells were grown in a three-dimensional (3-D) cell culture model and used to test the effects of a 20 Hz sinusoidal electromagnetic field (EMF; 6 mT and 113 mV/cm max) on collagen type I mRNA expression and extracellular matrix formation in comparison with the effects of growth factors. The cells were isolated from trabecular bone of a healthy individual (HO-197) and from a patient presenting with myositis ossificans (MO-192) and grown in a collagenous sponge-like substrate. Maximal enhancement of collagen type I expression after EMF treatment was 3.7-fold in HO-197 cells and 5.4-fold in MO-192 cells. Similar enhancement was found after transforming growth factor-beta (TGF-beta) and insulin-like growth factor-I (IGF-I) treatment. Combined treatment of the cells with EMF and the two growth factors TGF-beta and IGF-I did not act synergistically. MO-192 cells produced an osteoblast-characteristic extracellular matrix containing collagen type I, alkaline phosphatase, and osteocalcin, together with collagen type III, TP-1, and TP-3, two epitopes of an osteoblastic differentiation marker. The data suggest that the effects of EMFs on osteoblastic differentiation are comparable to those of TGF-beta and IGF-I. We conclude that EMF effects in the treatment of skeletal disorders and in orthopedic adjuvant therapy are mediated via enhancement of collagen type I mRNA expression, which may lead to extensive extracellular matrix synthesis.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
benefit
Population
Human osteoblastic cells isolated from trabecular bone of a healthy individual (HO-197) and a patient with myositis ossificans (MO-192), grown in a 3-D culture model
Sample size
—
Exposure
ELF <1 MHz
Evidence strength
Low
Confidence: 78% · Peer-reviewed: yes

Main findings

A 20 Hz sinusoidal EMF (6 mT; 113 mV/cm max) increased collagen type I mRNA expression, with maximal enhancement of 3.7-fold in HO-197 cells and 5.4-fold in MO-192 cells. Similar enhancement was observed with TGF-beta and IGF-I; combined EMF plus growth factors was not synergistic. MO-192 cells produced an osteoblast-characteristic extracellular matrix, and the authors conclude EMF effects may be mediated via enhanced collagen type I mRNA expression leading to extracellular matrix synthesis.

Outcomes measured

  • Collagen type I mRNA expression
  • Extracellular matrix formation/synthesis
  • Osteoblastic differentiation markers (e.g.
  • alkaline phosphatase
  • osteocalcin
  • TP-1
  • TP-3)

Limitations

  • In vitro 3-D cell culture model
  • findings may not translate to in vivo/clinical outcomes
  • Cells derived from only two donors (one healthy individual and one patient)
  • limiting generalizability
  • Exposure duration and exposure schedule not stated in the abstract
View raw extracted JSON
{
  "study_type": "in_vitro",
  "exposure": {
    "band": "ELF",
    "source": null,
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Human osteoblastic cells isolated from trabecular bone of a healthy individual (HO-197) and a patient with myositis ossificans (MO-192), grown in a 3-D culture model",
  "sample_size": null,
  "outcomes": [
    "Collagen type I mRNA expression",
    "Extracellular matrix formation/synthesis",
    "Osteoblastic differentiation markers (e.g., alkaline phosphatase, osteocalcin, TP-1, TP-3)"
  ],
  "main_findings": "A 20 Hz sinusoidal EMF (6 mT; 113 mV/cm max) increased collagen type I mRNA expression, with maximal enhancement of 3.7-fold in HO-197 cells and 5.4-fold in MO-192 cells. Similar enhancement was observed with TGF-beta and IGF-I; combined EMF plus growth factors was not synergistic. MO-192 cells produced an osteoblast-characteristic extracellular matrix, and the authors conclude EMF effects may be mediated via enhanced collagen type I mRNA expression leading to extracellular matrix synthesis.",
  "effect_direction": "benefit",
  "limitations": [
    "In vitro 3-D cell culture model; findings may not translate to in vivo/clinical outcomes",
    "Cells derived from only two donors (one healthy individual and one patient), limiting generalizability",
    "Exposure duration and exposure schedule not stated in the abstract"
  ],
  "evidence_strength": "low",
  "confidence": 0.78,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "extremely low frequency",
    "ELF EMF",
    "20 Hz",
    "6 mT",
    "osteoblast",
    "human osteoblastic cells",
    "collagen type I",
    "mRNA expression",
    "extracellular matrix",
    "TGF-beta",
    "IGF-I",
    "myositis ossificans",
    "3-D culture"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 5391

Effects of extremely low frequency electromagnetic field (EMF) on collagen type I mRNA expression and extracellular matrix synthesis of human osteoblastic cells. · Non-native EMF